Xingfei Yu

576 total citations
28 papers, 394 citations indexed

About

Xingfei Yu is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Xingfei Yu has authored 28 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Oncology and 10 papers in Genetics. Recurrent topics in Xingfei Yu's work include Breast Cancer Treatment Studies (11 papers), Estrogen and related hormone effects (6 papers) and HER2/EGFR in Cancer Research (6 papers). Xingfei Yu is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Estrogen and related hormone effects (6 papers) and HER2/EGFR in Cancer Research (6 papers). Xingfei Yu collaborates with scholars based in China, Czechia and Taiwan. Xingfei Yu's co-authors include Hongjian Yang, Hongjian Yang, Xiaofan Wu, Xiangming He, Jiang‐Jiang Qin, Yabing Zheng, Xianghou Xia, Zhanhong Chen, Yang Yu and Lei Lei and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Xingfei Yu

28 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingfei Yu China 12 177 175 115 85 64 28 394
Petar Ozretić Croatia 17 127 0.7× 497 2.8× 182 1.6× 113 1.3× 46 0.7× 52 664
Liang-Ping Xia China 9 77 0.4× 206 1.2× 181 1.6× 29 0.3× 66 1.0× 13 424
Masaki Okafuji Japan 10 94 0.5× 264 1.5× 138 1.2× 63 0.7× 32 0.5× 17 424
Qing-Xia Fan China 13 73 0.4× 187 1.1× 106 0.9× 18 0.2× 13 0.2× 39 403
Arata Shimo Japan 11 139 0.8× 397 2.3× 154 1.3× 37 0.4× 55 0.9× 17 610
Agnieszka Gdowicz‐Kłosok Poland 9 85 0.5× 216 1.2× 114 1.0× 22 0.3× 47 0.7× 22 300
Satoru Nakayama Japan 14 150 0.8× 429 2.5× 131 1.1× 18 0.2× 190 3.0× 35 737
Maryann Mikhail United States 9 94 0.5× 158 0.9× 140 1.2× 18 0.2× 29 0.5× 16 365
P. Athanassiadou Greece 11 76 0.4× 159 0.9× 96 0.8× 26 0.3× 43 0.7× 46 417
Karen Jung Canada 12 91 0.5× 220 1.3× 106 0.9× 21 0.2× 26 0.4× 19 334

Countries citing papers authored by Xingfei Yu

Since Specialization
Citations

This map shows the geographic impact of Xingfei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingfei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingfei Yu more than expected).

Fields of papers citing papers by Xingfei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingfei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingfei Yu. The network helps show where Xingfei Yu may publish in the future.

Co-authorship network of co-authors of Xingfei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingfei Yu. A scholar is included among the top collaborators of Xingfei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingfei Yu. Xingfei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Mengjie, et al.. (2025). Experimental study the effect of differences in heat transfer in different freezing directions on the distribution characteristic of trapped bubbles in ice slices. International Communications in Heat and Mass Transfer. 167. 109295–109295. 1 indexed citations
2.
Ouyang, Qi, Xishan Wang, Chuan Tian, et al.. (2024). 347MO The safety and efficacy of ivonescimab in combination with chemotherapy as first-line (1L) treatment for triple-negative breast cancer (TNBC). Annals of Oncology. 35. S360–S361. 5 indexed citations
3.
Huang, Yu‐An, Lei Shi, Lisha Ying, et al.. (2023). Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-α via SNHG17/Hippo-YAP axis. Breast Cancer Research and Treatment. 203(3). 613–625. 3 indexed citations
4.
Wu, Xiaofan, Hongjian Yang, Xingfei Yu, & Jiang‐Jiang Qin. (2022). Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies. Frontiers in Pharmacology. 13. 1012552–1012552. 50 indexed citations
5.
Qiao, Enqi, et al.. (2021). Curcuma zedoaria petroleum ether extract reverses the resistance of triple-negative breast cancer to docetaxel via pregnane X receptor. Annals of Translational Medicine. 9(17). 1389–1389. 3 indexed citations
6.
Ding, Yuqin, Xingfei Yu, Dehong Zou, et al.. (2020). Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer. PLoS ONE. 15(4). e0231895–e0231895. 25 indexed citations
7.
Qiao, Enqi, Xingfei Yu, Lingyan Zhou, et al.. (2019). A Prospective Validation Cohort Study of a Prediction Model on Non-sentinel Lymph Node Involvement in Early Breast Cancer. Annals of Surgical Oncology. 27(5). 1653–1658. 5 indexed citations
8.
Wang, Chen, Qiang Huang, Yiwen Zhang, et al.. (2019). Effect of cimicifuga racemosa on menopausal syndrome caused by LHRH-a in breast cancer. Journal of Ethnopharmacology. 238. 111840–111840. 11 indexed citations
9.
Wang, Chen, et al.. (2018). Knockdown of ribosomal protein S15A inhibits proliferation of breast cancer cells through induction of apoptosis in vitro. Cytotechnology. 70(5). 1315–1323. 9 indexed citations
10.
Wang, Chen, Hongjian Yang, Xingfei Yu, et al.. (2018). The Dysregulated Expression of KCNQ1OT1 and Its Interaction with Downstream Factors miR-145/CCNE2 in Breast Cancer Cells. Cellular Physiology and Biochemistry. 49(2). 432–446. 57 indexed citations
11.
Wang, Chen & Xingfei Yu. (2018). The protective effects of gonadotropin-releasing hormone agonist on ovarian functions in breast Cancer patients receiving chemotherapy.. PubMed. 25(135). 7–12. 1 indexed citations
12.
Yu, Xingfei, et al.. (2017). The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study. ESMO Open. 2(2). e000134–e000134. 7 indexed citations
13.
Lei, Lei, Xingfei Yu, Bo Chen, Zhanhong Chen, & Xiaojia Wang. (2016). Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study. PLoS ONE. 11(5). e0155132–e0155132. 37 indexed citations
14.
Yu, Xingfei, Hongjian Yang, Lei Lei, Chen Wang, & Jian Huang. (2016). CK19 mRNA in blood can predict non-sentinel lymph node metastasis in breast cancer. Oncotarget. 7(21). 30504–30510. 7 indexed citations
15.
Yu, Xingfei, et al.. (2015). A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC). PLoS ONE. 10(8). e0136670–e0136670. 18 indexed citations
16.
Xia, Xianghou, Wenjuan Yin, Xiping Zhang, et al.. (2015). PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer. Oncology Letters. 10(3). 1501–1506. 15 indexed citations
17.
Zhang, Xiping, Xiang Zhang, Hongjian Yang, et al.. (2015). [Treatment of Chemotherapy Related Leukocytopenia by Oral Administration of Multiple Leucogenic Drugs Combined with G-CSF: an Experimental Study].. PubMed. 35(7). 860–5. 2 indexed citations
18.
Yang, Hongjian, Yabing Zheng, Xingfei Yu, et al.. (2014). shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells. Cancer Chemotherapy and Pharmacology. 73(3). 569–576. 29 indexed citations
19.
Yu, Xingfei, et al.. (2013). The prognostic significance of molecular subtype for male breast cancer: A 10-year retrospective study. The Breast. 22(5). 824–827. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petar Ozretić Breakdown of academic impact, for papers by Liang-Ping Xia Breakdown of academic impact, for papers by Masaki Okafuji Breakdown of academic impact, for papers by Qing-Xia Fan Breakdown of academic impact, for papers by Arata Shimo Breakdown of academic impact, for papers by Agnieszka Gdowicz‐Kłosok Breakdown of academic impact, for papers by Satoru Nakayama Breakdown of academic impact, for papers by Maryann Mikhail Breakdown of academic impact, for papers by P. Athanassiadou Breakdown of academic impact, for papers by Karen Jung
Rankless by CCL
2026